Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let’s do trials with endpoints we know we can hit. Longhaulers would be good for certain maladies but not all inclusive. Let’s stop trying to be the world cured of all ills and more of a precision medicine
One thing you never run out of is milk with Nader. He milks everything and everyone
Culumbus sailed the ocean blue and Leronlimab will change my red to black. I picked out a nice suit for the big Nasdaq announcement coming in 2021. BLA will be here 2025. All Naders time frame trust me
Wow. Seems like the boat has sprung a leak. Good luck and congrats to those who made some money. That is the whole idea of investing to make money.
Get the feeling there will be some big developments before end of week. Stay tuned
There is so much noise in politics right now the way I see it is a vaccine will be ready by end of October right before election the way Trump wants it. He will coerce the HHS and Azar who superseded FDA to get Trump what he wants. Then there is NIH and are generic MAB which will be all the rage while we are pushed to fill out S/C to 390. Unless U.K. and MHRA throw us a lifeline and say ok EINDS are enough with all the other data from S/C trial and MM we are toast. Forget uplist that has about a 10% chance at the rate we are going. Lastly if BLA suffers any setbacks the SP will be back under $1
Columbus Day as was already posted. We sail onward with Leronlimab to the new world
First thing the call says 15 minutes for them and 45 minutes for questions. It’s more the other way around which if the CC doesn’t turn into a nothingburger is better that way. Can you imagine if there were 45 minutes dedicated to questions? Geez
Sure hope I am but just possibly I’m not. Time not on our side and enrolling to complete 390 may just put us on the outside looking in
All other indications are great I agree that we need a quick approval or EUA to save lives and start generating revenue. Covid is the most pressing issue where we may have the quickest way to get Leronlimab noticed. BLA for HIV is huge also but will take at least 6 months. If we have to fully enroll I feel we will be very late to the party. Too many drugs very close to the finish line which could get EUA before us.
I see the window of opportunity closing everyday for COVID-19. In very short time, numerous BP will have the results of their vaccine trials which if results are 50% effective they will be approved. Many countries already have approved vaccines for their citizens and IMO with our government using operation warp speed and the money they have invested, we are toast. Vaccines cost will be free of nominal in price while Leronlimab will cost $3 grand. Just don’t have that much faith in the system. Unless CD-12 results knock the cover off the ball we will need full enrollment. This may take at least 3 months to fill and then 38 days after that. Our chances and percentages of approvals drop every day. The competition is fierce and many companies do not have as many internal problems with financing and CEO underperformance.
Some say they love Naders transparency. I call them fantasy and lies. Once credibility is lost, it is hard to be trusted and I think IMO that is where a lot of investors are. At the start all we heard were timelines that never panned out. Then there were trials and submissions that just fisappeared into thin sir. Over promise and under deliver. Hype and pump z a nd then sell shares. No one seems to believe most of what he says. EUA applies for or not. Just tell the truth. PRs with factual content and results instead of piecemeal open ended promises. On CCs goes off on a tangent and yells at caller. Is that what kind of captain we need to navigate this ship in troubled wAters? And the kicker is to ask for a vote on 100 million shares for the purpose of using them maybe 5-10% for talent and revenue raise to wait only one month and ask for 25 million shares to line your pocket. This is also after the fact that he gave himself the golden parachute in case of buyout? Who is kidding who here. The self centered greediness is unnecessary. If just one indication and acceptance comes, the board will have more $ than they know what to do with. GLTA and my proxy vote is a big N O . Get something done like an approval and come back in six months and ask again or restructure current one to eliminate bonuses and just shares for talent and hiring.
Dream catchers and root beer floats for everyone.
Nader said he will pick up the tab for the big shareholder party in Vegas if he is granted his share of stock if proxy vote is yes.
Be prepared for a 4pm proactive video conference will Christine Corrado to tell everyone he is doing great. And that the new flavor of the day is exciting news about theBBB and the start of nine new trials now for Alzheimer’s, stroke, ALS, MS, etc.
Seeing a big bounce today once tempers calm down. Stop with all the conspiracy theories.?Results from Cd-12 will be out by Columbus Day and we will sail off to the pasture known as revenues. Leronlimab will not be stopped. The drug works period. The FDA doesn’t care about Nader and his nationality or that he filed for bankruptcy or any of that nonsense. They are not a parole board. It’s very possible that we will still have to complete the 390 for them to say ok. Most of the problem is that the treatments for Covid have kept people alive and many new cases are from younger people getting Covid. Less chance for death. Trials are slow to enroll because everyone is looking for patients with so many trials being run at the same time.
Nader will try n sell you sand from the beach. He is horrible braggadocio self centered and needs to take a back seat. Each CC it is more painfully obvious that there are way too many turnovers than can be tolerated. We definitely know it is not the FDA by the way he constantly praises there efforts to tolerate his ineptitude. So the article posted in the Portland paper was spot on. The pin on this grenade has been pulled and his time is running out. This stock can either explode with an approval or be blown to smitherines with one more screw up.GLTA
Rock Leo for consideration onBOD for Cytodyn
Nader is a constant juggler with too many balls in the air. Many have said focus and accomplish one approval and the floodgates will open. If CD-12 is a miss this could get ugly real fast. No catalysts for quite some time- 3 strikes your out of BLA is screwed up again. I’m voting yes for additional shares and yes across the board on all proxies. Everyone deserves a second , I mean third, I mean fourth chance to get things right.
So let’s see you announce a conference call 6 days in advance and then you show up with nothing. Did anyone notice on most of the previous CCs and PRs Nader was always putting timelines on things that were always missed. So now when he was asked about it directly he blew up and said I wish you understand these things don’t happen overnight. They may take years. He starts the pump all the time and creates the buzz and now he flips out and throws a tantrum. Very unprepared and unprofessional IMO. These calls are meant to be informative with solid language not false hopes and promises. Obviously most are waiting on CD -12 results but don’t sound the alarm until they have been processed. Like the MM fawning all over safety results but no efficacy til weeks later. Have all the results needed to move the needle in a forward way.
Nader not getting the McDonald’s job. Overqualified to make fries.
Looks like the only way I’m gonna make any money here is to start snorting heavy tomorrow. Good chance I can make back all the money I’ve lost Buying in at $10.01
Dr Otto Yang and DR JL were not on the call today because they were in a meeting with Warren Buffet to get $5.95 financing from him
Covid will be long gone before anything gets approvals and BLA 1-2 years out. Massive solution needed to stay afloat without buyout or some sort of merger. IMO
Timberrrrr is what I’m hearing. If it walks like a duck and quacks like a duck it must be a duck. And hearing no PR prior to the call has this sounding like an ugly duckling. Sure can use a rabbit to pull from the hat. Let’s see if the magic Nader is pulling tomorrow is smoke and mirrors or does he really have something up his sleeve. If going by prior CCs it would seem like there will be a lot of wool being pulled over peoples eyes. Really hope I’m wrong but maybe CD-12 results will be the equalizer. One can dream can’t one????
Fed announcement. EUA for Leronlimab now we can get back to some sense of normalcy. Details to follow$5.95
Death by a thousand cuts if tomorrow is a delay and nothingburger. Unless there is substantial news and not the usual fluff this will drop like a rock. Let’s see if NP and his underwings answer the tough questions instead of the softballs that are usually given to them. And let’s hope they are answered in a truthful manner. If it’s bad it’s bad. Stop acting like politicians and avoiding direct questions. What happened to Nasdaq filing? What happened to multiple offers from BP? Where are we going from here? What are top line results for MM? What is the real reason for delay to BLA? I’d it really about needles? No more fluff? Do you really expect shareholders to approve 25 million shares to line your bank account when there are 0 approvals? No revenues? Just pie in the sky promises. Produce and get an approval and then 25 million shares can be discussed. Let’s see how things pan out.
We may need a plumber tomorrow as it’s very possible there will be some leaking prior to the CC. Could have started today. Who knows. GLTA
So it’s unfortunate that we are not being bought out or being used in combo with their drugs but in essence we have the best drug as far as safety goes and the trials are showing that if used in MM there are many benefits as well as safety. Three weeks from now we will have the results of S/C and when u add efficacy to the safety, we will be given an EUA. Second wave of Covid is amongst many countries that are locking down now. And the long haulers will be the top of the iceberg when Leronlimab proves to be the cure for their maladies. Throw in the fact that there are very positive developments with the BLA for HIV and we have a runway to large gains without partners.
So let me get this straight. You have dome of the top doctors in their fields join your scientific advisory board because they love to jump on a sinking ship that offers no upside? Makes perfect sense to me. How about that even though our CEO is very braggadocio, maybe like building a house, the foundation is being poured using a solid foundation. IMO things take time. We know that vaccines are being touted as the savior to get us out of this pandemic, but how many people really trust anyone in government. The expression is how can you tell when a politician is lying? When they speak. It is so obviythat govt is in bed with the lobbyists and s hills that promote not what is best for our country but what is best for their financial well being. There is a ton of money to be lost if you can take a shot and go home as compared to an IV where you need to be hospitalized for 11 days. Penny wise & dollar foolish. But what does the govt care when it is the taxpayers who are on the hook for the bill. Get real people & read the tea leaves
Nader is not lying when he says he sees triple digit share price $5.95
Seems to me there are too many CEOs on this board and not enough shareholders
Latane great response. Saving lives is the priority and restoring life back to some sense of normalcy, not being afraid to leave the house, go out to eat, catch a movie without the fear of catching COVID and dying worst case or being a long hauler.
So let’s see last conference call no questions were to be asked other than related to the results of the trial. Any other questions would not be answered. So I’m guessing that will be the same format for this conference call. He will pass the baton a few times to speakers, talk about meeting with MHRA and FDA. Give grandiose outcomes and great forward looking outcomes, yet still not deliver any approvals. Seems like the goal line has went from inches to yards and now the opposite end zone. Will anyone be allowed to ask about his insane request for additional 25 million shares ?
Seeing $3
32 trading hours a lot can happen in that window of time.
Strategy. Don’t ever underestimate the underdog.
I believe
Agreed that things take time but it’s how it is presented by the CEO that has shareholders in a tizzy. It always has the feel of a pump and the finish line is never being crossed. I understand that impatience gets the best of us, but it also doesn’t help when business is overstated. It is a long journey so I plan to enjoy all the ups and downs that a pre revenue Bio has to offer
Sources say NDAs in effect. Reason for silence. Stay long stay strong stay strong look for PR after hours tomorrow.